[96a5a0]: / output / allTrials / identified / NCT00294762_identified.json

Download this file

304 lines (304 with data), 11.6 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
{
"info": {
"nct_id": "NCT00294762",
"official_title": "A Phase 2 Randomized Study of Tarceva (Erlotinib) as a Single Agent or Intercalated With Combination Chemotherapy in Patients With Newly Diagnosed Advanced Non-small Cell Lung Cancer Who Have Tumors With EGFR Protein Overexpression and/or Increased EGFR Gene Copy Numbers",
"inclusion_criteria": "* Age >= 18\n* Histologically or cytologically documented non-small cell lung cancer (NSCLC)\n* Eastern Cooperative Oncology Group (ECOG)performance status (PS)0, 1, 2\n* Radiologically measurable or evaluable disease No prior chemotherapy\n* 1 or 2 epithelial growth factor receptor (EGFR) pathway markers positive at screening\n* Tumor tissue block or fine needle aspirate\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Any concurrent anticancer therapy or radiation\n* Other active malignancy\n* Uncontrolled brain metastases\n* GI abnormalities\n* Severe abnormalities of the cornea\n* Significant cardiac disease\n* Active infection",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Age >= 18",
"criterions": [
{
"exact_snippets": "Age >= 18",
"criterion": "age",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
]
}
]
},
{
"line": "* Histologically or cytologically documented non-small cell lung cancer (NSCLC)",
"criterions": [
{
"exact_snippets": "Histologically or cytologically documented non-small cell lung cancer (NSCLC)",
"criterion": "non-small cell lung cancer (NSCLC)",
"requirements": [
{
"requirement_type": "documentation",
"expected_value": [
"histologically",
"cytologically"
]
}
]
}
]
},
{
"line": "* Radiologically measurable or evaluable disease No prior chemotherapy",
"criterions": [
{
"exact_snippets": "Radiologically measurable or evaluable disease",
"criterion": "disease",
"requirements": [
{
"requirement_type": "evaluation method",
"expected_value": [
"radiologically measurable",
"evaluable"
]
}
]
},
{
"exact_snippets": "No prior chemotherapy",
"criterion": "prior chemotherapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* 1 or 2 epithelial growth factor receptor (EGFR) pathway markers positive at screening",
"criterions": [
{
"exact_snippets": "1 or 2 epithelial growth factor receptor (EGFR) pathway markers positive at screening",
"criterion": "epithelial growth factor receptor (EGFR) pathway markers",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": "=",
"value": 1,
"unit": "N/A"
}
},
{
"requirement_type": "quantity",
"expected_value": {
"operator": "=",
"value": 2,
"unit": "N/A"
}
},
{
"requirement_type": "status",
"expected_value": "positive"
},
{
"requirement_type": "timing",
"expected_value": "at screening"
}
]
}
]
},
{
"line": "* Tumor tissue block or fine needle aspirate",
"criterions": [
{
"exact_snippets": "Tumor tissue block or fine needle aspirate",
"criterion": "tumor tissue",
"requirements": [
{
"requirement_type": "type",
"expected_value": [
"block",
"fine needle aspirate"
]
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Any concurrent anticancer therapy or radiation",
"criterions": [
{
"exact_snippets": "Any concurrent anticancer therapy",
"criterion": "concurrent anticancer therapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "Any concurrent ... radiation",
"criterion": "concurrent radiation",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Other active malignancy",
"criterions": [
{
"exact_snippets": "Other active malignancy",
"criterion": "active malignancy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Uncontrolled brain metastases",
"criterions": [
{
"exact_snippets": "Uncontrolled brain metastases",
"criterion": "brain metastases",
"requirements": [
{
"requirement_type": "control status",
"expected_value": "uncontrolled"
}
]
}
]
},
{
"line": "* GI abnormalities",
"criterions": [
{
"exact_snippets": "GI abnormalities",
"criterion": "GI abnormalities",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Severe abnormalities of the cornea",
"criterions": [
{
"exact_snippets": "Severe abnormalities of the cornea",
"criterion": "cornea abnormalities",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "severe"
}
]
}
]
},
{
"line": "* Significant cardiac disease",
"criterions": [
{
"exact_snippets": "Significant cardiac disease",
"criterion": "cardiac disease",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "significant"
}
]
}
]
},
{
"line": "* Active infection",
"criterions": [
{
"exact_snippets": "Active infection",
"criterion": "infection",
"requirements": [
{
"requirement_type": "status",
"expected_value": "active"
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [
{
"line": "* Eastern Cooperative Oncology Group (ECOG)performance status (PS)0, 1, 2",
"criterions": [
{
"exact_snippets": "Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1, 2",
"criterion": "ECOG performance status",
"requirements": [
{
"requirement_type": "value",
"expected_value": [
"0",
"1",
"2"
]
}
]
}
]
}
],
"failed_exclusion": [],
"failed_miscellaneous": []
}